MSR79 Matching Plus Regression Adjustment for the Estimation of the Average Treatment Effect on Survival Outcomes: A Case Study with Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma

Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.2138
https://www.valueinhealthjournal.com/article/S1098-3015(23)05268-3/fulltext
Title : MSR79 Matching Plus Regression Adjustment for the Estimation of the Average Treatment Effect on Survival Outcomes: A Case Study with Mosunetuzumab in Relapsed/Refractory Follicular Lymphoma
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05268-3&doi=10.1016/j.jval.2023.09.2138
First page :
Section Title :
Open access? : No
Section Order : 11583
Categories :
Tags :
Regions :
ViH Article Tags :